Clinical Trial Update: Efficacy of Etoricoxib on Peripheral Hyperalgesia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing etoricoxib for peripheral hyperalgesia was terminated; the study covered several neuropathic pain conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type Ii
• Peripheral Nerve Injury
• Polyneuropathy
• Postherpetic Neuralgia
• Radiculopathy

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Causalgia, Polyneuropathy | Phase 2 | Status: TERMINATED